基本信息
浏览量:192
职业迁徙
个人简介
Her clinical and research interests include various topics in breast cancer, such as angiogenesis, breast cancer in younger women, endocrine therapy, novel HER2 therapies, breast cancer vaccines, and other experimental therapeutics for breast cancer. As board certified in medical oncology, she maintains an active clinical practice of over 500 patients and has served as the PI or co-PI on over 50 clinical trials in breast cancer, including pivotal phase II and III trials that led to the approval of lapatinib for the treatment of HER2-positive breast cancer, and the recently published EMILIA trial assessing the safety and efficacy of T-DM1 in HER2-positive metastatic breast cancer. She is a past recipient of the Duke University Specialized Program of Research Excellence (SPORE) in breast cancer Young Investigator Award, the Duke Cancer Center Malek Family Award for outstanding cancer investigation, and the Joseph Greenfield Award for Research Mentorship. She serves on the national Scientific Advisory Board of the Susan G Komen for the Cure, the CALGB Correlative Science Core Committee, as well as the Steering Committee Chair for CHAMBER (Collaborations for HeAlth IMprovements in HER2+ Breast CancER). She has authored or co-authored over 60 articles or book chapters appearing in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Cancer, Radiation Research, and Molecular Cancer Therapeutics.
研究兴趣
论文共 182 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn